Premium
Dapsone versus topical immunotherapy in alopecia areata
Author(s) -
BAAR H.M.J.,
VLEUTEN C.J.M.,
KERKHOF P.C.M.
Publication year - 1995
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1995.tb02628.x
Subject(s) - dapsone , alopecia areata , medicine , dermatology , immunotherapy , cancer
Summary Twenty‐seven patients with severe alopecia areata were treated with dapsone. The results of a mean treatment duration of 10±0.5 months are reported, and compared with the results of long‐term topical immunotherapy obtained previously at the same institute. The efficacy of dapsone proved to be markedly inferior to that of topical immunotherapy. The percentage of patients showing regrowth of hair during treatment with dapsone was comparable with the occurrence of spontaneous regrowth of hair reported in the literature.